Skip to main content
Premium Trial:

Request an Annual Quote

Proteros to Generate Leads for J&J

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Proteros Biostructures said today that it has agreed to investigate potential small molecule lead compounds for Johnson & Johnson Pharmaceutical Research and Development (J&JPRD).

Under the partnership agreement, Proteros will use its lead discovery service, which employs structural biology, screening of an in-house compound and fragment library, compound profiling, and medicinal chemistry activities, to find leads against a specific target provided by J&JPRD.

The Martinsried, Germany-based firm said its service speeds up protein structure analysis and structure-based discovery with its expertise and processes for crystallography and fragment-based lead generation.

Financial terms of the agreement were not released.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.